• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

U.S. Federal Trade Commission

The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024
Pharma

Teva moves to delist 200-plus patents from FDA registry: FTC

Teva has asked the FDA to remove hundreds of patents from its registry, according to the FTC.
Eric Sagonowsky Dec 10, 2025 4:58pm
stack of letters mail envelopes
Favicon Fierce Biotech

Pfizer finalizes Metsera buy after contentious Novo bidding war

Nov 13, 2025 12:43pm
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024
Favicon Fierce Biotech

FTC tells Novo that Metsera offer may violate US merger law

Nov 5, 2025 4:26pm
Sign on doorway for FTC in Washington DC

Trump's nominee to chair the FTC could bode well for pharma M&A

Dec 11, 2024 11:25am
healthcare policy politics US healthcare

Biopharma status quo likely to persist under Trump 2.0: analyst

Nov 21, 2024 1:15pm
MA

Roche CEO critiques Novo's proposed Catalent buyout

Oct 23, 2024 12:35pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings